📰 ET Markets 🔴 BEARISH 🕒 26 Oct 2026, 05:31 AM IST

Nifty outlook: Can the index rebound despite bearish signals?

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Nifty outlook: Can the index rebound despite bearish signals?

📊

Market & Financial Impact: The Nifty index fell over 2% amid sustained selling pressures with technical indicators signaling support levels. Analysts have identified crucial resistance levels and potential near-term recovery points for the index. Several stocks have shown strength and recommendations have been made for buying opportunities. Additionally, bearish momentum remains evident in specific sectors while futures strategies are advised. Overall, investors are encouraged to adopt a cautious approach during this volatile period.

💡

Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

While bearish signals dominate the broader outlook, a close above a key technical indicator suggests scope for a near-term recovery.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Will oil turn into a lingering problem? Is the world economy, India, or the market prepared?

KYB and KYC: Business behind the wealth creator called ‘Divi’s Lab’ – Part 2, concluding

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Nifty outlook: Can the index rebound despite bearish signals?

🔥 More Live Market Stories

Capital shifting from secondary market to ₹5 trillion IPO pipeline: Madhu Lunawat

Infosys’s huge deal wins fail to give it an edge over peers

Double-digit growth seen on corporate scoreboard in Q2, but bank, IT, pharma lags

Asian shares make cautious start, Brent eases from six-month high

Ramelius Q1 FY27 slides: cash surges to A$768M as growth ramps

Earnings call transcript: Artrya lifts outlook in Q1 2026 as stock falls